Back
Appili Therapeutics Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
29
APLIF
Appili Therapeutics
Last Price:
0.02
Seasonality Move:
-9.36%
Buy
65
AUPH
Aurinia Pharmaceuticals
Last Price:
8.13
Seasonality Move:
30.05%
Sell
29
Appili Therapeutics (APLIF)
is a Sell
Is Appili Therapeutics a Buy, Sell or Hold?
- The current Appili Therapeutics [APLIF] share price is $0.02. The Score for APLIF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- APLIF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.12. The Score for AUPH is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLIF Stock Price Chart
What is Appili Therapeutics's stock price today?
-
The Appili Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLIF is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.12
The current trend is moderately bullish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
APLIF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 46.37 | Sell |
| Chaikin Money Flow: | 118182 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.03 - 0.03) | Sell |
| Bollinger Bands (100): | (0.03 - 0.03) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 62.64 | Buy |
| Chaikin Money Flow: | -992405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.99 - 8.03) | Buy |
| Bollinger Bands (100): | (5.72 - 7.42) | Buy |
APLIF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.02 | Sell |
| 20-day SMA: | 0.03 | Sell |
| 50-day SMA: | 0.02 | Sell |
| 200-day SMA: | 0.03 | Sell |
| 8-day EMA: | 0.02 | Sell |
| 20-day EMA: | 0.03 | Sell |
| 50-day EMA: | 0.03 | Sell |
| 200-day EMA: | 0.03 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.22 | Sell |
| 20-day SMA: | 7.61 | Buy |
| 50-day SMA: | 7.27 | Buy |
| 200-day SMA: | 6.08 | Buy |
| 8-day EMA: | 8.12 | Sell |
| 20-day EMA: | 7.76 | Buy |
| 50-day EMA: | 7.28 | Buy |
| 200-day EMA: | 6.76 | Buy |
Appili Therapeutics Earnings Growth & APLIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Appili Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||